Hematopoietic growth factors and high-dose chemotherapy: will grams succeed where milligrams fail?
Demetri
G D
GD
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Griffin
J D
JD
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control; D013921:Thrombocytopenia / Q000139:chemically induced / Q000517:prevention & control
D000970:Antineoplastic Agents; D003115:Colony-Stimulating Factors; D006133:Growth Substances; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor